Skip to main content
Mia Levy, MD, Oncology, Evanston, IL

Mia A Levy MD PhD

Oncology•Evanston, IL

Breast Cancer

Director, Rush University Cancer Center

Join to view full profile

  • 2650 Ridge Ave.Kellogg Cancer CenterEvanston, IL 60201

  • Phone+1 847-570-2112

  • Fax+1 847-570-1041

Dr. Levy is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Levy's full profileAlready have an account?

Education & Training

  • Sutter Health/California Pacific Medical Center
    Sutter Health/California Pacific Medical CenterResidency, Gastroenterology, 2020 - 2026
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2003 - 2005
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2004 - Present
  • IL State Medical License
    IL State Medical License 2020 - 2029
  • TN State Medical License
    TN State Medical License 2009 - 2021
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification StarPanel, Vanderbilt University, 2012, 2014-2017
  • CMS Meaningful Use Stage 1 Certification StarPanel, Vanderbilt University, 2012, 2014-2017
  • CMS Meaningful Use Stage 2 Certification BI-Clinical, CitiusTech, Inc., 2012, 2014-2017

Publications & Presentations

PubMed

Journal Articles

  • Clinical Application of Computational Methods in Precision Oncology  
    Mia A Levy, Christopher R Cogle, JAMA Oncology
  • Qualitative Study of System-Level Factors Related to Genomic Implementation  
    Geoffrey S Ginsburg, Joshua C Denny, Carol R Horowitz, Mia A Levy, Barbara A Bernhardt, Paul R Dexter, Stephen E Kimmel, Lori A Orlando, Nature

Authored Content

  • Clinical Application of Computational Methods in Precision OncologyMay 2020
  • Clinical Application of Computational Methods in Precision OncologyMay 2020

Press Mentions

  • U.S. Food and Drug Administration Approves FoundationOne®Liquid CDx as a Companion Diagnostic for TEPMETKO® (Tepotinib) to Identify Patients with MET Exon 14 Skipping Alterations in Non-Small Cell Lung Cancer
    U.S. Food and Drug Administration Approves FoundationOne®Liquid CDx as a Companion Diagnostic for TEPMETKO® (Tepotinib) to Identify Patients with MET Exon 14 Skipping Alterations in Non-Small Cell Lung CancerNovember 18th, 2024
  • U.S. Food and Drug Administration Approves FoundationOne®Liquid CDx as a Companion Diagnostic for Itovebi™ (Inavolisib) to Identify Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer with a PIK3CA Mutation
    U.S. Food and Drug Administration Approves FoundationOne®Liquid CDx as a Companion Diagnostic for Itovebi™ (Inavolisib) to Identify Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer with a PIK3CA MutationOctober 11th, 2024
  • Foundation Medicine and Its Collaborators Announce Acceptance of 21 Abstracts at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
    Foundation Medicine and Its Collaborators Announce Acceptance of 21 Abstracts at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingMay 26th, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Mia Levy, Dr. Mia Levy, MD, Dr. M Levy, Dr. Mia A Levy